Sign in
Taking people in United StatesPhase 2

Shockwave therapy added to botulinum toxin for muscle stiffness after spinal cord injury

Tests shockwave therapy alongside botulinum toxin for spasticity in adults with spinal cord injury.

Key facts

Who runs it
Kessler Foundation
Where
West Orange, United StatesSee the site
Trial code
Registry title
Extracorporeal Shockwave Therapy as an Additional Treatment for Spasticity Secondary to Spinal Cord Injury
Status
Recruiting
Phase
Phase 2
People taking part
30 people, planned
Started
21 Sept 2026
Expected to end
31 Aug 2028
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Focused extracorporeal shockwave therapy
  • Botulinum toxin
  • Sham
Record updated
4 November 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with spasticity (stiff, tight muscles) after a spinal cord injury who already get BoNT (botulinum toxin) injections in the calf muscles.

Age
18 years and older
Sex
Women and men
Disease stage
Spinal cord injury that is not getting worse, complete or incomplete, with lasting nerve problems. The injury happened more than 1 year before joining. Ankle muscle stiffness on the modified Ashworth scale (MAS) between 1+ and 3.
Earlier treatment
Must be getting BoNT now in the plantar flexor (calf) muscles. No change in spasticity medicines in the past 3 months, and none planned during the trial. No local phenol or alcohol injection in the last 12 months.

Main reasons for not taking part

  • Past surgery on the legs, or a stiff, fixed ankle (contracture)
  • Blood clots, use of blood thinners, or severe bleeding problems
  • Pregnancy or cancer
  • Severe inflammatory arthritis, or infection at the treatment site
  • Cannot have an MRI (for example fear of closed spaces, or metal implants or fragments)

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Women and men, age 18 years and older
  • Non-progressive SCI (complete or incomplete) with residual neurological deficits that occurred greater than 1 year prior to enrollment
  • Ankle flexor modified Ashworth scale (MAS) of between 1+ and 3, inclusive
  • No contraindication to f-ESWT, including current or recent infection at the treatment site and severe coagulopathies
  • No change in antispasmodic medications within the past 3 months or intended changes during the trial
  • currently being treated with BoNT in the plantar flexor muscles

Who cannot take part

  • Anticoagulant medication
  • MRI contraindications (e.g. claustrophobia, ferromagnetic implants or debris)
  • History of lower limb surgical procedures
  • Severe, inflammatory arthritic diseases
  • Thrombosis
  • Cancer
  • Ankle contracture
  • Pregnancy
  • Recent (12 months) local phenol/alcohol injection

Where in United States

  • Kessler FoundationWest Orange, United StatesContact: Shalaka Paranjpe, MSTaking people

About the trial

What the trial wants to find out

Spasticity is a common consequence of spinal cord injury and can have a profound impact on quality of life. The goal of this study is to learn if an intervention called focused extracorporeal shockwave therapy can enhance the effectiveness of injections received for spasticity, such as Botox. The main questions this study seeks to answer are whether shockwave therapy and toxin injection 1) can improve spasticity symptoms greater than toxin injection alone, and 2) change the structure of the injected muscles. Researchers will compare the group who receives both shockwave therapy and toxin injection to a group who receives only toxin injection. Participants will be asked to visit the clinic five times over the span of three months. The first three visits will occur on three consecutive weeks, during which participants will receive shockwave therapy or the sham therapy. The final two visits will occur four and eight weeks later, during which participants will be asked a series of questions about their spasticity and have ultrasounds and MRIs collected of their leg muscles.

The 2 groups in the trial

  • Shockwave plus toxinTreatment being tested

    Shockwave therapy plus toxin injection

    Treatment: Focused extracorporeal shockwave therapy and Botulinum toxin

  • Sham plus toxinSham treatment, for comparison

    Toxin injection plus a sham (fake) shockwave therapy

    Treatment: Botulinum toxin and Sham

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Randomized, Sham-controlled Trial to Investigate Extracorporeal Shockwave Therapy as an Adjunctive Treatment for Spasticity Secondary to Spinal Cord Injury
Plain-language title
Shockwave therapy added to botulinum toxin for muscle stiffness after spinal cord injuryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
4 November 2026